Trial Information

Summary: The Effects of Rosiglitazone on Cognition in Patients with Mild Cognitive Impairment (MCI).

The UCLA Alzheimer Disease Center is looking for individuals with memory loss (MCI) to participate in a 20-month research study. The purpose of this study is to determine if improving the way insulin works to regulate blood sugar helps to improve memory in people with memory loss.

Study participation may involve:

• 12 study visits at UCLA
• Memory Tests
• Laboratory Tests
• Magnetic resonance imaging (MRI)
• May receive study medication (Rosiglitazone) or an inactive substance.

Patient Inclusion Criteria

• Have memory loss
• Age 55 or older

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:57 AM